MktsMarkets

IDEAYA Biosciences, Inc.
NASDAQ: IDYAKey statistics
IDYA News
Stories mentioning IDYA from around the web — every one is an open thread, so give it a like or add your take.
Loading news…
Financial statements
As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.
| Line item | Q1 '26Mar 31 | Q4 '25Dec 31 | Q3 '25Sep 30 | Q2 '25Jun 30 | Q1 '25Mar 31 | Q4 '24Dec 31 | Q3 '24Sep 30 | Q2 '24Jun 30 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | 6,560 | 207,834 | 7,000 | 0.00 | 0.00 | |||
| Cost of Goods Sold | ||||||||
| Gross Profit | 0.00 | 0.00 | 0.00 | |||||
| Operating Expenses | ||||||||
| Research & Development | 95,726 | 86,599 | 82,993 | 74,226 | 70,886 | 140,183 | 57,152 | 54,533 |
| Sales General & Admin | ||||||||
| Total Operating Expenses | 115,104 | 105,446 | 99,382 | 88,806 | 84,389 | 151,138 | 66,893 | 64,927 |
| Operating Income (Loss) | (108,544) | (94,570) | 108,452 | (88,806) | (84,389) | (144,138) | (66,893) | (64,927) |
| Interest Income | ||||||||
| Interest Expense | ||||||||
| Other Expense | ||||||||
| Pretax Income | ||||||||
| Tax Provision | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||
| Net Income (Loss) | (98,539) | (83,273) | 119,244 | (77,491) | (72,178) | (130,312) | (51,821) | (52,772) |
| Earnings Per Share (Basic) | (1.11) | (0.94) | 1.35 | (0.88) | (0.82) | (1.60) | (0.60) | (0.68) |
| Earnings Per Share (Diluted) | (1.11) | (0.94) | 1.33 | (0.88) | (0.82) | (1.60) | (0.60) | (0.68) |
| Weighted Average Shares Outstanding (Basic) | 88,700 | 88,485 | 88,527 | 88,472 | 88,356 | 81,678 | 86,189 | 77,963 |
| Weighted Average Shares Outstanding (Diluted) | 88,700 | 88,485 | 89,691 | 88,472 | 88,356 | 81,678 | 86,189 | 77,963 |
Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.
About IDYA
IDEAYA Biosciences, Inc. (NASDAQ: IDYA) is a stock listed on the Nasdaq Stock Market under the ticker symbol IDYA. It last traded at $26.17 (Nov 19, 2026, 9:30 AM ET), down 1.2% on the day. That gives IDEAYA Biosciences a market capitalisation of $3.2B.
Over the past 52 weeks IDYA has traded between $25.75 and $42.68.
Revenue for the quarter ended Mar 31, 2026 was $6.6M; a net loss of $98.5M.
| Quarter ended | Revenue | Net income | Margin |
|---|---|---|---|
| Mar 31, 2026 | $6.6M | -$98.5M | -1502.1% |
| Dec 31, 2025 | — | -$83.3M | — |
| Sep 30, 2025 | $207.8M | $119.2M | 57.4% |
| Jun 30, 2025 | — | -$77.5M | — |
From IDEAYA Biosciences’s quarterly (10-Q) filings, in US dollars.
Take a break — play a market game
Seven free games built around the markets. No download, no sign-up: they run right here in your browser.
Latest News
Market news from around the web — every story is an open thread, so give it a like or add your take.
Loading news…